Literature DB >> 21458155

Anatomic features of enhancing renal masses predict malignant and high-grade pathology: a preoperative nomogram using the RENAL Nephrometry score.

Alexander Kutikov1, Marc C Smaldone, Brian L Egleston, Brandon J Manley, Daniel J Canter, Jay Simhan, Stephen A Boorjian, Rosalia Viterbo, David Y T Chen, Richard E Greenberg, Robert G Uzzo.   

Abstract

BACKGROUND: Counseling patients with enhancing renal mass currently occurs in the context of significant uncertainty regarding tumor pathology.
OBJECTIVE: We evaluated whether radiographic features of renal masses could predict tumor pathology and developed a comprehensive nomogram to quantitate the likelihood of malignancy and high-grade pathology based on these features. DESIGN, SETTING, AND PARTICIPANTS: We retrospectively queried Fox Chase Cancer Center's prospectively maintained database for consecutive renal masses where a Nephrometry score was available. INTERVENTION: All patients in the cohort underwent either partial or radical nephrectomy. MEASUREMENTS: The individual components of Nephrometry were compared with histology and grade of resected tumors. We used multiple logistic regression to develop nomograms predicting the malignancy of tumors and likelihood of high-grade disease among malignant tumors. RESULTS AND LIMITATIONS: Nephrometry score was available for 525 of 1750 renal masses. Nephrometry score correlated with both tumor grade (p < 0.0001) and histology (p < 0.0001), such that small endophytic nonhilar tumors were more likely to represent benign pathology. Conversely, large interpolar and hilar tumors more often represented high-grade cancers. The resulting nomogram from these data offers a useful tool for the preoperative prediction of tumor histology (area under the curve [AUC]: 0.76) and grade (AUC: 0.73). The model was subjected to out-of-sample cross-validation; however, lack of external validation is a limitation of the study.
CONCLUSIONS: The current study is the first to objectify the relationship between tumor anatomy and pathology. Using the Nephrometry score, we developed a tool to quantitate the preoperative likelihood of malignant and high-grade pathology of an enhancing renal mass.
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21458155      PMCID: PMC3124570          DOI: 10.1016/j.eururo.2011.03.029

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  26 in total

Review 1.  Renal mass biopsy--a renaissance?

Authors:  Brian R Lane; Mary K Samplaski; Brian R Herts; Ming Zhou; Andrew C Novick; Steven C Campbell
Journal:  J Urol       Date:  2007-11-13       Impact factor: 7.450

2.  Accuracy of percutaneous core biopsy in management of small renal masses.

Authors:  Rou Wang; J Stuart Wolf; David P Wood; Ellen J Higgins; Khaled S Hafez
Journal:  Urology       Date:  2009-01-01       Impact factor: 2.649

3.  Renal masses--to treat or not to treat? If that is the question are contemporary biomarkers the answer?

Authors:  Robert G Uzzo
Journal:  J Urol       Date:  2008-06-11       Impact factor: 7.450

4.  Renal cell carcinoma: prognostic significance of incidentally detected tumors.

Authors:  K H Tsui; O Shvarts; R B Smith; R Figlin; J B de Kernion; A Belldegrun
Journal:  J Urol       Date:  2000-02       Impact factor: 7.450

5.  Clinical predictors of renal mass pathological features.

Authors:  Matvey Tsivian; Vladimir Mouraviev; David M Albala; Jorge R Caso; Cary N Robertson; John F Madden; Thomas J Polascik
Journal:  BJU Int       Date:  2010-11-05       Impact factor: 5.588

6.  Rising incidence of small renal masses: a need to reassess treatment effect.

Authors:  John M Hollingsworth; David C Miller; Stephanie Daignault; Brent K Hollenbeck
Journal:  J Natl Cancer Inst       Date:  2006-09-20       Impact factor: 13.506

7.  Tailoring technique of laparoscopic partial nephrectomy to tumor characteristics.

Authors:  Alon Z Weizer; Scott M Gilbert; William W Roberts; Brent K Hollenbeck; J Stuart Wolf
Journal:  J Urol       Date:  2008-08-15       Impact factor: 7.450

8.  Survival rates after resection for localized kidney cancer: 1989 to 2004.

Authors:  Paul Russo; Thomas L Jang; Joseph A Pettus; William C Huang; Scott E Eggener; Matthew F O'Brien; Michael E Karellas; Nicholas T Karanikolas; Megan A Kagiwada
Journal:  Cancer       Date:  2008-07-01       Impact factor: 6.860

9.  A preoperative prognostic nomogram for solid enhancing renal tumors 7 cm or less amenable to partial nephrectomy.

Authors:  Brian R Lane; Denise Babineau; Michael W Kattan; Andrew C Novick; Inderbir S Gill; Ming Zhou; Christopher J Weight; Steven C Campbell
Journal:  J Urol       Date:  2007-06-11       Impact factor: 7.450

10.  Histopathological characteristics of localized renal cell carcinoma correlate with tumor size: a SEER analysis.

Authors:  Jason Rothman; Brian Egleston; Yu-Ning Wong; Kevan Iffrig; Steve Lebovitch; Robert G Uzzo
Journal:  J Urol       Date:  2008-11-13       Impact factor: 7.450

View more
  76 in total

1.  Prediction of perioperative outcomes following minimally invasive partial nephrectomy: role of the R.E.N.A.L nephrometry score.

Authors:  Zhuo-Wei Liu; Ephrem O Olweny; Gang Yin; Stephen Faddegon; Yung K Tan; Woong Kyu Han; Jeffrey A Cadeddu
Journal:  World J Urol       Date:  2012-04-28       Impact factor: 4.226

Review 2.  The role of minimally invasive surgery in multifocal renal cell carcinoma.

Authors:  Serge Ginzburg; Robert G Uzzo; Alexander Kutikov
Journal:  Curr Urol Rep       Date:  2012-06       Impact factor: 3.092

3.  Perioperative morbidity, oncological outcomes and predictors of pT3a upstaging for patients undergoing partial nephrectomy for cT1 tumors.

Authors:  Pascal Mouracade; Onder Kara; Julien Dagenais; M J Maurice; R J Nelson; Ercan Malkoc; J H Kaouk
Journal:  World J Urol       Date:  2017-02-14       Impact factor: 4.226

4.  Pre-treatment neutrophil-to-lymphocyte ratio predicts tumor pathology in newly diagnosed renal tumors.

Authors:  Boyd R Viers; R Houston Thompson; Christine M Lohse; John C Cheville; Bradley C Leibovich; Stephen A Boorjian; Matthew K Tollefson
Journal:  World J Urol       Date:  2016-04-06       Impact factor: 4.226

5.  Surgeon-specific factors affecting treatment decisions among Canadian urologists in the management of pT1a renal tumours.

Authors:  Alexandra Leora Millman; Kenneth T Pace; Michael Ordon; Jason Young Lee
Journal:  Can Urol Assoc J       Date:  2014-05       Impact factor: 1.862

6.  Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?

Authors:  Reza Mehrazin; Marc C Smaldone; Brian Egleston; Jeffrey J Tomaszewski; Charles W Concodora; Timothy K Ito; Philip H Abbosh; David Y T Chen; Alexander Kutikov; Robert G Uzzo
Journal:  Urol Oncol       Date:  2015-03-14       Impact factor: 3.498

Review 7.  Decision Making: Thermal Ablation Options for Small Renal Masses.

Authors:  Colin J McCarthy; Debra A Gervais
Journal:  Semin Intervent Radiol       Date:  2017-06-01       Impact factor: 1.513

8.  Robotic and open partial nephrectomy for localized renal tumors larger than 7 cm: a single-center experience.

Authors:  Ercan Malkoc; Daniel Ramirez; Onder Kara; Matthew J Maurice; Ryan J Nelson; Peter A Caputo; Jihad H Kaouk
Journal:  World J Urol       Date:  2016-09-23       Impact factor: 4.226

9.  Preoperative predictors of malignancy and unfavorable pathology for clinical T1a tumors treated with partial nephrectomy: a multi-institutional analysis.

Authors:  Mark W Ball; Michael A Gorin; Sam B Bhayani; Craig G Rogers; Michael D Stifelman; Jihad H Kaouk; Homayoun Zargar; Susan Marshall; Jeffrey A Larson; Haider M Rahbar; Bruce J Trock; Phillip M Pierorazio; Mohamad E Allaf
Journal:  Urol Oncol       Date:  2014-12-11       Impact factor: 3.498

Review 10.  A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy.

Authors:  Tobias Klatte; Vincenzo Ficarra; Christian Gratzke; Jihad Kaouk; Alexander Kutikov; Veronica Macchi; Alexandre Mottrie; Francesco Porpiglia; James Porter; Craig G Rogers; Paul Russo; R Houston Thompson; Robert G Uzzo; Christopher G Wood; Inderbir S Gill
Journal:  Eur Urol       Date:  2015-04-22       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.